-
TMB in ELISA: From Redox Chemistry to Malaria
2026-09-14
TMB connects peroxidase chemistry with sensitive serological readouts. This guide explains how 3,3′,5,5′-Tetramethylbenzidine can support epitope-based Plasmodium vivax surveillance while preserving rigorous controls, cutoff validation, and assay interpretation.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-14
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, cellular, patient, and mouse-model evidence provides a mechanistic framework for linking tumor glycolysis with immune-checkpoint response, while also defining important limits for translating LDHA-focused experiments.
-
Bromodomain Inhibitor, (+)-JQ1: Ferroptosis Workflows
2026-09-13
Bromodomain Inhibitor, (+)-JQ1 provides a practical way to connect BET-dependent chromatin regulation with ferroptosis, apoptosis, inflammation, and BRDT biology. This guide converts the latest BRD4–ROS–FSP1 findings into a controlled cell-assay workflow with application-specific controls and troubleshooting strategies.
-
DAF-2 diacetate for Nitric Oxide Imaging
2026-09-12
DAF-2 diacetate combines cell permeability, intracellular retention, and sensitive fluorescence for mapping nitric oxide in live cells and experimental tissues. This practical guide connects probe handling with sulfur-dependent redox biology, including assay designs for endothelial, immune, neuronal, and soybean nodule research.
-
Bromodomain Inhibitor, (+)-JQ1 Workflow Guide
2026-09-11
Build reproducible BRD4 and BET-bromodomain experiments with (+)-JQ1, from dose-response and apoptosis assays to ferroptosis-combination studies. This workflow emphasizes solvent control, orthogonal readouts, and cell-context interpretation so researchers can distinguish transcriptional inhibition from downstream cell-death effects.
-
Lactate–GPR81–RAC1 Control of Glucose Uptake
2026-09-11
The 2026 Cell Research study identifies L-lactate as an insulin-independent regulator of skeletal-muscle glucose uptake and connects this effect to a GPR81–FARP1–RAC1–GLUT4 signaling axis. Its genetic, metabolic, and human-association evidence suggests that exercise-associated lactate may complement insulin signaling, while also defining experimental opportunities and limits for testing RAC1-dependent glucose transport.
-
Fosinopril Sodium: From Endpoints to Assays
2026-09-10
Fosinopril sodium offers a precise framework for hypertension research, but its value depends on connecting ACE target engagement with hemodynamic, renal, and cardiac endpoints. This article translates lessons from the VERTIS CV outcomes trial into a practical, evidence-aware assay strategy.
-
A-1210477: MCL-1 Inhibitor Workflow
2026-09-10
A-1210477 enables selective interrogation of MCL-1-dependent survival, mitochondrial apoptosis, and combination responses in cancer models. This practical guide connects compound handling with mechanism-focused assays, controls, and troubleshooting for reproducible cancer research.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-09
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator in colorectal cancer, linking ENO1 acetylation and lactate production to TRAF6-dependent PD-L1 stabilization. Its combination of database analysis, multi-omics, patient data, and mouse models provides a mechanistic framework for understanding how tumor glycolysis can influence checkpoint blockade response.
-
α-Linolenic Acid: Designing Causal Lipid Assays
2026-09-09
Explore how α-Linolenic Acid and ALA can be studied as metabolic substrates, membrane inputs, and signaling modifiers. This evidence-aware guide uses a recent arachidonic acid immunology study to develop more rigorous assay logic without conflating ALA with arachidonic acid.
-
How Impending Cell Death Can Seed Metastasis
2026-09-08
Conod, Silvano, and Ruiz i Altaba show that tumor cells surviving an impending-death experience can acquire stable prometastatic states called PAMEs. The study links these states to ER stress, PERK-CHOP signaling, GLI and NANOG-dependent reprogramming, and a cytokine-mediated interaction with neighboring PIM cells, providing a mechanistic framework for how treatment-associated stress may promote dissemination.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-09-08
Qiu and colleagues show that phenothiazines strengthen macrophage control of intracellular bacteria through coordinated reactive oxygen species accumulation, lysosomal activation, and autophagy. The study supports a host-directed antibacterial strategy, while its class-level design means that compound-specific effects, including those of promethazine hydrochloride, require separate validation.
-
Oral Colon Cancer Nanotherapy with Dextran Microgels
2026-09-07
The reference study developed an orally administered, colon-responsive system in which dextran microgels protect cisplatin/SPION lipid nanoparticles during gastrointestinal transit and release them in the colon. Its combination of dextran- and folic-acid-mediated targeting with chemotherapy and magnetic hyperthermia produced strong antitumor activity in an orthotopic mouse model while illustrating the formulation challenges that must be addressed before clinical translation.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-07
Zeng and colleagues developed chemically modified p21 mRNA-loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. Their preclinical evidence links restored nuclear p21 expression with cell-cycle suppression, DNA-damage signaling, apoptosis, tumor growth inhibition, and preservation of bladder architecture, while also highlighting delivery and translational constraints.
-
Regorafenib Workflows for Cancer Biology
2026-09-05
Build reproducible angiogenesis, migration, pathway, and tumor xenograft experiments with Regorafenib (BAY 73-4506). This practical guide connects multikinase inhibition with the newer RRM2–ERK/E2F3 melanoma findings and provides assay-specific optimization strategies.